Rationale: Staphylococcus aureus is the most common respiratory pathogen isolated from patients with cystic fibrosis (CF) in the United States. Although modes of acquisition and genetic adaptation have been described for Pseudomonas aeruginosa, resulting in improved diagnosis and treatment, these features remain more poorly defined for S. aureus. Objectives: To characterize the molecular epidemiology and genetic adaptation of S. aureus during chronic CF airway infection and in response to antibiotic therapy. Methods: We performed whole-genome sequencing of 1,382 S. aureus isolates collected longitudinally over a mean 2.2 years from 246 children with CF at five U.S. centers between 2008 and 2017. Results were integrated with clinical and demographic data to characterize bacterial population dynamics and identify common genetic targets of in vivo adaptation.Measurements and Main Results: Results showed that 45.5% of patients carried multiple, coexisting S. aureus lineages, often having different antibiotic susceptibility profiles. Adaptation during the course of infection commonly occurred in a set of genes related to persistence and antimicrobial resistance. Individual sequence types demonstrated wide geographic distribution, and we identified limited strain-sharing among children linked by common household or clinical exposures. Unlike P. aeruginosa, S. aureus genetic diversity was unconstrained, with an ongoing flow of new genetic elements into the population of isolates from children with CF.Conclusions: CF airways are frequently coinfected by multiple, genetically distinct S. aureus lineages, indicating that current clinical procedures for sampling isolates and selecting antibiotics are likely inadequate. Strains can be shared by patients in close domestic or clinical contact and can undergo convergent evolution in key persistence and antimicrobial-resistance genes, suggesting novel diagnostic and therapeutic approaches for future study.
Rationale: Staphylococcus aureus is the most common respiratory pathogen isolated from patients with cystic fibrosis (CF) in the United States. Although modes of acquisition and genetic adaptation have been described for Pseudomonas aeruginosa, resulting in improved diagnosis and treatment, these features remain more poorly defined for S. aureus. Objectives: To characterize the molecular epidemiology and genetic adaptation of S. aureus during chronic CF airway infection and in response to antibiotic therapy. Methods: We performed whole-genome sequencing of 1,382 S. aureus isolates collected longitudinally over a mean 2.2 years from 246 children with CF at five U.S. centers between 2008 and 2017. Results were integrated with clinical and demographic data to characterize bacterial population dynamics and identify common genetic targets of in vivo adaptation.Measurements and Main Results: Results showed that 45.5% of patients carried multiple, coexisting S. aureus lineages, often having different antibiotic susceptibility profiles. Adaptation during the course of infection commonly occurred in a set of genes related to persistence and antimicrobial resistance. Individual sequence types demonstrated wide geographic distribution, and we identified limited strain-sharing among children linked by common household or clinical exposures. Unlike P. aeruginosa, S. aureus genetic diversity was unconstrained, with an ongoing flow of new genetic elements into the population of isolates from children with CF.Conclusions: CF airways are frequently coinfected by multiple, genetically distinct S. aureus lineages, indicating that current clinical procedures for sampling isolates and selecting antibiotics are likely inadequate. Strains can be shared by patients in close domestic or clinical contact and can undergo convergent evolution in key persistence and antimicrobial-resistance genes, suggesting novel diagnostic and therapeutic approaches for future study.
Authors: Eric E Smith; Danielle G Buckley; Zaining Wu; Channakhone Saenphimmachak; Lucas R Hoffman; David A D'Argenio; Samuel I Miller; Bonnie W Ramsey; David P Speert; Samuel M Moskowitz; Jane L Burns; Rajinder Kaul; Maynard V Olson Journal: Proc Natl Acad Sci U S A Date: 2006-05-10 Impact factor: 11.205
Authors: Lisa Saiman; Jane D Siegel; John J LiPuma; Rebekah F Brown; Elizabeth A Bryson; Mary Jo Chambers; Veronica S Downer; Jill Fliege; Leslie A Hazle; Manu Jain; Bruce C Marshall; Catherine O'Malley; Suzanne R Pattee; Gail Potter-Bynoe; Siobhan Reid; Karen A Robinson; Kathryn A Sabadosa; H Joel Schmidt; Elizabeth Tullis; Jennifer Webber; David J Weber Journal: Infect Control Hosp Epidemiol Date: 2014-07-01 Impact factor: 3.254
Authors: Indranil Chatterjee; Andre Kriegeskorte; Andreas Fischer; Susanne Deiwick; Nadine Theimann; Richard A Proctor; Georg Peters; Mathias Herrmann; Barbara C Kahl Journal: J Bacteriol Date: 2007-09-28 Impact factor: 3.490
Authors: Claudio Donati; N Luisa Hiller; Hervé Tettelin; Alessandro Muzzi; Nicholas J Croucher; Samuel V Angiuoli; Marco Oggioni; Julie C Dunning Hotopp; Fen Z Hu; David R Riley; Antonello Covacci; Tim J Mitchell; Stephen D Bentley; Morgens Kilian; Garth D Ehrlich; Rino Rappuoli; E Richard Moxon; Vega Masignani Journal: Genome Biol Date: 2010-10-29 Impact factor: 13.583
Authors: Shaun D Jackman; Benjamin P Vandervalk; Hamid Mohamadi; Justin Chu; Sarah Yeo; S Austin Hammond; Golnaz Jahesh; Hamza Khan; Lauren Coombe; Rene L Warren; Inanc Birol Journal: Genome Res Date: 2017-02-23 Impact factor: 9.043
Authors: Nicole Mayer-Hamblett; George Retsch-Bogart; Margaret Kloster; Frank Accurso; Margaret Rosenfeld; Gary Albers; Philip Black; Perry Brown; AnneMarie Cairns; Stephanie D Davis; Gavin R Graff; Gwendolyn S Kerby; David Orenstein; Rachael Buckingham; Bonnie W Ramsey Journal: Am J Respir Crit Care Med Date: 2018-11-01 Impact factor: 30.528
Authors: Qing Tang; Mimi R Precit; Maureen K Thomason; Sophie F Blanc; Fariha Ahmed-Qadri; Adelle P McFarland; Daniel J Wolter; Lucas R Hoffman; Joshua J Woodward Journal: Cell Host Microbe Date: 2022-04-18 Impact factor: 31.316
Authors: Erick Forno; Steven H Abman; Jagdev Singh; Mary E Robbins; Hiran Selvadurai; Paul T Schumacker; Paul D Robinson Journal: Am J Respir Crit Care Med Date: 2021-08-01 Impact factor: 30.528
Authors: Sarah J Morgan; Samantha L Durfey; Sumedha Ravishankar; Peter Jorth; Wendy Ni; Duncan T Skerrett; Moira L Aitken; Edward F McKone; Stephen J Salipante; Matthew C Radey; Pradeep K Singh Journal: JCI Insight Date: 2021-12-22
Authors: Edward F McKone; Pradeep K Singh; Samantha L Durfey; Sudhakar Pipavath; Anna Li; Anh T Vo; Anina Ratjen; Suzanne Carter; Sarah J Morgan; Matthew C Radey; Brenda Grogan; Stephen J Salipante; Michael J Welsh; David A Stoltz; Christopher H Goss Journal: mBio Date: 2021-12-14 Impact factor: 7.867
Authors: Stefano G Giulieri; Romain Guérillot; Sebastian Duchene; Abderrahman Hachani; Diane Daniel; Torsten Seemann; Joshua S Davis; Steven Y C Tong; Bernadette C Young; Daniel J Wilson; Timothy P Stinear; Benjamin P Howden Journal: Elife Date: 2022-06-14 Impact factor: 8.713
Authors: Harry S Porterfield; Lucas J Maakestad; Mason M LaMarche; Andrew L Thurman; Zoe E Kienenberger; Nicholas J Pitcher; Alexis R Hansen; Christian F Zirbes; Linda Boyken; Bethany L Muyskens; Alejandro A Pezzulo; Sachinkumar B Singh; Erik Twait; Bradley Ford; Daniel J Diekema; Valérie Reeb; Anthony J Fischer Journal: Pediatr Pulmonol Date: 2021-07-16
Authors: Marie K Wieneke; Felix Dach; Claudia Neumann; Dennis Görlich; Lena Kaese; Theo Thißen; Angelika Dübbers; Christina Kessler; Jörg Große-Onnebrink; Peter Küster; Holger Schültingkemper; Bianca Schwartbeck; Johannes Roth; Jerzy-Roch Nofer; Janina Treffon; Julia Posdorfer; Josefine Marie Boecken; Mariele Strake; Miriam Abdo; Sophia Westhues; Barbara C Kahl Journal: mSphere Date: 2021-06-23 Impact factor: 4.389